{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16004804", "DateCompleted": {"Year": "2007", "Month": "02", "Day": "06"}, "DateRevised": {"Year": "2015", "Month": "03", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"JournalIssue": {"Volume": "24", "Issue": "7", "PubDate": {"Year": "2005", "Month": "Jul"}}, "Title": "Ai zheng = Aizheng = Chinese journal of cancer", "ISOAbbreviation": "Ai Zheng"}, "ArticleTitle": "[Effect of triptolide on expression of urokinase-type plasminogen activators in vascular endothelial cells].", "Pagination": {"StartPage": "801", "EndPage": "805", "MedlinePgn": "801-5"}, "Abstract": {"AbstractText": ["It has been showed that triptolide (T10) has antitumor activities. This study was to observe the inhibitory effects of T10 on proliferation of vascular endothelial cells and expression of urokinase-type plasminogen activator (u-PA), and to elucidate the antiangiogenic mechanism of T10.", "Human umbilical vein endothelial cells were cultured in vitro for 3 generations, and treated with T10 (0, 5, 10, 20, and 30 microg/L), or dexamethasone (300 mg/L) as control. Cell count and 3H-TDR incorporation were used to observe cell proliferation. The chick embryo chorioallantoic membrane (CAM) test was carried out to observe the effect of T10 on angiogenesis. Immunohistochemistry and real-time quantitive reverse transcription-polymerase chain reaction (RT-PCR) were used to detect protein and mRNA levels of u-PA.", "T10 inhibited the proliferation of umbilical vein endothelial cells in a dose-dependent manner; inhibitory rate of endothelial cells was 28.93% after treatment of 5 microg/L of T10. T10 significantly reduced angiogenesis in CAM, even at the concentration of 5 microg/L (P<0.05). T10 decreased protein and mRNA levels of u-PA in endothelial cells in a dose-dependent manner; the protein level of u-PA was reduced by 41.05% after treatment of 5 microg/L of T10.", "T10 could inhibit the proliferation of human umbilical vein endothelial cells and expression of u-PA, which may contribute to its antiangiogenic activity."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Sichuan University, Chengdu, Sichuan, 610041, PR China."}], "Identifier": [], "LastName": "Ding", "ForeName": "Yi", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Jie", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhao", "ForeName": "Qing-Liang", "Initials": "QL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hou", "ForeName": "Li-Jun", "Initials": "LJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Qiu-Lin", "Initials": "QL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Shu-Ren", "Initials": "SR"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Ai Zheng", "NlmUniqueID": "9424852"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiogenesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Alkylating"}, {"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Epoxy Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenanthrenes"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "19ALD1S53J", "NameOfSubstance": "triptolide"}, {"RegistryNumber": "EC 3.4.21.73", "NameOfSubstance": "Urokinase-Type Plasminogen Activator"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Angiogenesis Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Alkylating"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Chick Embryo"}, {"QualifierName": ["blood supply"], "DescriptorName": "Chorioallantoic Membrane"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Diterpenes"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["cytology", "metabolism"], "DescriptorName": "Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Epoxy Compounds"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Phenanthrenes"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tripterygium"}, {"QualifierName": ["cytology", "metabolism"], "DescriptorName": "Umbilical Veins"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Urokinase-Type Plasminogen Activator"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "7", "Day": "12", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "2", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "7", "Day": "12", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16004804", "1000467X2005070801"]}}], "PubmedBookArticle": []}